February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read
October 23, 2017 | Compliance EU MDR/IVDR Compliance – A Roadmap for Success John McShane Managing Partner, Validant 1 Minute Read
October 14, 2017 | Press Releases Validant Cares Makes an Impact in Ireland Carla Nieser 1 Minute Read